Jin Medical International (ZJYL)
Customizable rehabilitation wheelchairs and living aids for dealer markets.
Something off on this page? Send us feedback.
Designs and manufactures rehabilitation wheelchairs, components, and living aids, selling mainly through dealers in Japan and China. Most sales are OEM, while the listed Cayman holding company controls its China operating business contractually rather than through equity ownership.
Designs and manufactures customizable rehabilitation wheelchairs, wheelchair components, and living-aid products for people with disabilities, older people, and people recovering from injury. The wider product range includes oxygen concentrators, bath aids, rehabilitative devices, oxygen chambers, beauty instruments, and nano products.
Sells principally through dealers in Japan and China, with smaller volumes in North America, Australia, Korea, Israel, Singapore, and other markets. Most product sales are OEM for third parties, alongside company-branded products; Nissin Medical is both the largest customer and sole Japanese distributor.
Operates the established business through a China-based VIE and its subsidiaries. The listed Cayman parent has no material operations or equity ownership in that VIE, relying on contractual arrangements for control and economic exposure.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $30.1M · Total debt $20.6M · Total assets $55.8M · Shareholders' equity $30.3M
- Revenue
- $8.9M
- Operating income
- −$644.5K
- Net income
- −$107.7K
No dividends on record.
| Institutions2 holders · as of Mar 31, 2026 | 0.06% | 4.3K shares | |
| Insiders1 holder · as of Apr 24, 2026 | 67.79% | 5.31M shares | |
| Otherremainder | 32.15% | 2.52M shares |
7.83M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Erqi WangInsiderdirector, 10 percent owner, officer: Chief Executive Officer | 67.79% | 4.31M · 1.00M | Form 4filed Apr 24, 2026 ↗ |
Advisor Group Holdings, Inc.Institution | 0.04% | 3,100 | 13Fas of Mar 31, 2026 |
UBS Group AGInstitution | 0.02% | 1,223 | 13Fas of Mar 31, 2026 |
Novastralist Horizon Ltd.Strategic | —10.46% of class, as filed | — | 13Gfiled Aug 18, 2026 ↗ |
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report
Insider tradesForm 4
Nothing filed in the last 12 months.
Not reported.